Glen Santangelo
Stock Analyst at Barclays
(3.17)
# 1,131
Out of 5,127 analysts
117
Total ratings
49.37%
Success rate
1.43%
Average return
Main Sectors:
Stocks Rated by Glen Santangelo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IDXX IDEXX Laboratories | Maintains: Overweight | $850 → $800 | $646.53 | +23.74% | 2 | Feb 5, 2026 | |
| TEVA Teva Pharmaceutical Industries | Maintains: Overweight | $35 → $38 | $34.37 | +10.56% | 7 | Jan 30, 2026 | |
| GDRX GoodRx Holdings | Downgrades: Hold | $5.25 → $2.75 | $2.33 | +18.03% | 3 | Jan 22, 2026 | |
| MDLN Medline | Initiates: Overweight | $50 | $45.29 | +10.40% | 1 | Jan 12, 2026 | |
| COLL Collegium Pharmaceutical | Maintains: Overweight | $58 → $56 | $46.74 | +19.81% | 5 | Jan 9, 2026 | |
| PHR Phreesia | Maintains: Overweight | $26 → $24 | $12.41 | +93.39% | 3 | Dec 16, 2025 | |
| ZTS Zoetis | Initiates: Equal-Weight | $136 | $128.13 | +6.14% | 2 | Dec 9, 2025 | |
| XERS Xeris Biopharma Holdings | Initiates: Overweight | $9 | $7.22 | +24.65% | 3 | Dec 9, 2025 | |
| VTRS Viatris | Initiates: Overweight | $15 | $15.95 | -5.96% | 5 | Dec 9, 2025 | |
| TDOC Teladoc Health | Initiates: Equal-Weight | $8.5 | $4.85 | +75.26% | 8 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $100 | $65.91 | +51.72% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $3.5 | $3.90 | -10.26% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $29 | $21.50 | +34.92% | 5 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $16 | $12.82 | +24.80% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $27 | $21.24 | +27.12% | 6 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $86 | $81.04 | +6.13% | 3 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $118 | $78.35 | +50.61% | 7 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $24 | $30.17 | -20.45% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $30 | $25.61 | +17.14% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $63 | $27.24 | +131.28% | 3 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $12 | $13.93 | -13.85% | 3 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $400 | $360.00 | +11.11% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $243 | $220.27 | +10.32% | 5 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $8 | $6.16 | +29.87% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $100 | $79.91 | +25.14% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $30 | $28.57 | +5.01% | 3 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $15 | $14.76 | +1.63% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $49 | $40.20 | +21.89% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $5 | $5.20 | -3.85% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $170 | $196.27 | -13.38% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $7.5 | $7.81 | -3.97% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $960 | $935.21 | +2.65% | 6 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $48 | $17.24 | +178.42% | 5 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $51 | $23.50 | +117.02% | 1 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $6.03 | +1,558.37% | 2 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $55 | $65.00 | -15.38% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $31 → $28 | $2.06 | +1,259.22% | 2 | Mar 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $120 | $4.41 | +2,621.09% | 3 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $1.89 | +1,804.76% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $75.70 | - | 3 | Mar 17, 2021 |
IDEXX Laboratories
Feb 5, 2026
Maintains: Overweight
Price Target: $850 → $800
Current: $646.53
Upside: +23.74%
Teva Pharmaceutical Industries
Jan 30, 2026
Maintains: Overweight
Price Target: $35 → $38
Current: $34.37
Upside: +10.56%
GoodRx Holdings
Jan 22, 2026
Downgrades: Hold
Price Target: $5.25 → $2.75
Current: $2.33
Upside: +18.03%
Medline
Jan 12, 2026
Initiates: Overweight
Price Target: $50
Current: $45.29
Upside: +10.40%
Collegium Pharmaceutical
Jan 9, 2026
Maintains: Overweight
Price Target: $58 → $56
Current: $46.74
Upside: +19.81%
Phreesia
Dec 16, 2025
Maintains: Overweight
Price Target: $26 → $24
Current: $12.41
Upside: +93.39%
Zoetis
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $136
Current: $128.13
Upside: +6.14%
Xeris Biopharma Holdings
Dec 9, 2025
Initiates: Overweight
Price Target: $9
Current: $7.22
Upside: +24.65%
Viatris
Dec 9, 2025
Initiates: Overweight
Price Target: $15
Current: $15.95
Upside: -5.96%
Teladoc Health
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $8.5
Current: $4.85
Upside: +75.26%
Dec 9, 2025
Initiates: Overweight
Price Target: $100
Current: $65.91
Upside: +51.72%
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $3.5
Current: $3.90
Upside: -10.26%
Dec 9, 2025
Initiates: Overweight
Price Target: $29
Current: $21.50
Upside: +34.92%
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $16
Current: $12.82
Upside: +24.80%
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $27
Current: $21.24
Upside: +27.12%
Dec 9, 2025
Initiates: Overweight
Price Target: $86
Current: $81.04
Upside: +6.13%
Dec 9, 2025
Initiates: Overweight
Price Target: $118
Current: $78.35
Upside: +50.61%
Dec 9, 2025
Initiates: Overweight
Price Target: $24
Current: $30.17
Upside: -20.45%
Dec 9, 2025
Initiates: Overweight
Price Target: $30
Current: $25.61
Upside: +17.14%
Dec 9, 2025
Initiates: Overweight
Price Target: $63
Current: $27.24
Upside: +131.28%
Dec 9, 2025
Initiates: Underweight
Price Target: $12
Current: $13.93
Upside: -13.85%
Dec 9, 2025
Initiates: Overweight
Price Target: $400
Current: $360.00
Upside: +11.11%
Dec 9, 2025
Initiates: Overweight
Price Target: $243
Current: $220.27
Upside: +10.32%
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $8
Current: $6.16
Upside: +29.87%
Dec 9, 2025
Initiates: Overweight
Price Target: $100
Current: $79.91
Upside: +25.14%
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $30
Current: $28.57
Upside: +5.01%
Dec 9, 2025
Initiates: Overweight
Price Target: $15
Current: $14.76
Upside: +1.63%
Dec 9, 2025
Initiates: Overweight
Price Target: $49
Current: $40.20
Upside: +21.89%
Dec 9, 2025
Initiates: Underweight
Price Target: $5
Current: $5.20
Upside: -3.85%
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $170
Current: $196.27
Upside: -13.38%
Dec 9, 2025
Initiates: Underweight
Price Target: $7.5
Current: $7.81
Upside: -3.97%
Dec 9, 2025
Initiates: Overweight
Price Target: $960
Current: $935.21
Upside: +2.65%
Dec 9, 2025
Initiates: Overweight
Price Target: $48
Current: $17.24
Upside: +178.42%
Feb 11, 2025
Initiates: Buy
Price Target: $51
Current: $23.50
Upside: +117.02%
Dec 15, 2023
Reiterates: Buy
Price Target: $100
Current: $6.03
Upside: +1,558.37%
Oct 21, 2022
Initiates: Hold
Price Target: $55
Current: $65.00
Upside: -15.38%
Mar 17, 2022
Upgrades: Buy
Price Target: $31 → $28
Current: $2.06
Upside: +1,259.22%
Dec 2, 2021
Initiates: Hold
Price Target: $120
Current: $4.41
Upside: +2,621.09%
Dec 2, 2021
Initiates: Buy
Price Target: $36
Current: $1.89
Upside: +1,804.76%
Mar 17, 2021
Downgrades: Neutral
Price Target: n/a
Current: $75.70
Upside: -